184 related articles for article (PubMed ID: 32375593)
1. Understanding Creutzfeldt-Jackob disease from a viewpoint of amyloidogenic evolvability.
Hashimoto M; Ho G; Takamatsu Y; Wada R; Sugama S; Waragai M; Masliah E; Takenouchi T
Prion; 2020 Dec; 14(1):1-8. PubMed ID: 32375593
[TBL] [Abstract][Full Text] [Related]
2. Evolvability and Neurodegenerative Disease: Antagonistic Pleiotropy Phenomena Derived from Amyloid Aggregates.
Hashimoto M; Ho G; Takamatsu Y; Shimizu Y; Sugama S; Takenouchi T; Waragai M; Masliah E
J Parkinsons Dis; 2018; 8(3):405-408. PubMed ID: 30010144
[TBL] [Abstract][Full Text] [Related]
3. Transgenerational Interaction of Alzheimer's Disease with Schizophrenia through Amyloid Evolvability.
Takamatsu Y; Ho G; Waragai M; Wada R; Sugama S; Takenouchi T; Masliah E; Hashimoto M
J Alzheimers Dis; 2019; 68(2):473-481. PubMed ID: 30741673
[TBL] [Abstract][Full Text] [Related]
4. Evolvability of Amyloidogenic Proteins in Human Brain.
Hashimoto M; Ho G; Sugama S; Takamatsu Y; Shimizu Y; Takenouchi T; Waragai M; Masliah E
J Alzheimers Dis; 2018; 62(1):73-83. PubMed ID: 29439348
[TBL] [Abstract][Full Text] [Related]
5. Differential involvement of amyloidogenic evolvability in oligodendropathies; Multiple Sclerosis and Multiple System Atrophy.
Wei J; Ho G; Masliah E; Hashimoto M
Prion; 2023 Dec; 17(1):29-34. PubMed ID: 36785484
[TBL] [Abstract][Full Text] [Related]
6. Possible Role of Amyloid Cross-Seeding in Evolvability and Neurodegenerative Disease.
Hashimoto M; Ho G; Takamatsu Y; Wada R; Sugama S; Takenouchi T; Waragai M; Masliah E
J Parkinsons Dis; 2019; 9(4):793-802. PubMed ID: 31524179
[TBL] [Abstract][Full Text] [Related]
7. Possible Role of the Polyglutamine Elongation in Evolution of Amyloid-Related Evolvability.
Hashimoto M; Ho G; Takamatsu Y; Wada R; Sugama S; Takenouchi T; Masliah E; Waragai M
J Huntingtons Dis; 2018; 7(4):297-307. PubMed ID: 30372687
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of prion protein in the vagus nerve in creutzfeldt-jakob disease.
Kresl P; Rahimi J; Gelpi E; Aldecoa I; Ricken G; Danics K; Keller E; Kovacs GG
Ann Neurol; 2019 May; 85(5):782-787. PubMed ID: 30801763
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease.
Wei J; Takamatsu Y; Wada R; Fujita M; Ho G; Masliah E; Hashimoto M
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33672048
[TBL] [Abstract][Full Text] [Related]
10. The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins.
Rossi M; Kai H; Baiardi S; Bartoletti-Stella A; Carlà B; Zenesini C; Capellari S; Kitamoto T; Parchi P
Acta Neuropathol Commun; 2019 Apr; 7(1):53. PubMed ID: 30961668
[TBL] [Abstract][Full Text] [Related]
11. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.
Carlson GA; Prusiner SB
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064393
[TBL] [Abstract][Full Text] [Related]
12. Connecting Alzheimer's Disease With Diabetes Mellitus Through Amyloidogenic Evolvability.
Ho G; Takamatsu Y; Wada R; Sugama S; Waragai M; Takenouchi T; Masliah E; Hashimoto M
Front Aging Neurosci; 2020; 12():576192. PubMed ID: 33192467
[TBL] [Abstract][Full Text] [Related]
13. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.
Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T
Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818
[TBL] [Abstract][Full Text] [Related]
14. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
[TBL] [Abstract][Full Text] [Related]
15. Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insigh
